Ross D. Cranston

发表

Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial?

William Brown, Curtis Dolezal, Mobolaji Ibitoye, 2018, J. Am. Medical Informatics Assoc..

Challenges and solutions implementing an SMS text message-based survey CASI and adherence reminders in an international biomedical HIV PrEP study (MTN 017)

William Brown, Luis Quispe, Mobolaji Ibitoye, 2018, J. Biomed. Informatics.

Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men.

Ross D. Cranston, J. Margolick, J. Phair, 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

Association of serum cytokines with oral HPV clearance.

Ross D. Cranston, J. Margolick, R. Burk, 2016, Cytokine.

Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.

Ross D. Cranston, E. Vittinghoff, J. Palefsky, 2004, The Journal of infectious diseases.

Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.

Ross D. Cranston, J. Margolick, M. Pawlita, 2016, Cancer epidemiology.

Anal Cancer Screening in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study

Ross D. Cranston, N. Joste, M. Plankey, 2016, Journal of acquired immune deficiency syndromes.

A Longitudinal Study of Human Papillomavirus 16 L1, E6, and E7 Seropositivity and Oral Human Papillomavirus 16 Infection

Ross D. Cranston, J. Margolick, E. Sugar, 2015, Sexually transmitted diseases.

Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults

Ross D. Cranston, J. Margolick, R. Burk, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Ross D. Cranston, J. Margolick, R. Burk, 2015, American journal of epidemiology.

Mucosal effects of tenofovir 1% gel

James Y. Dai, Ross D. Cranston, R. Gottardo, 2014, bioRxiv.

The association of medication use with clearance or persistence of oral HPV infection

Ross D. Cranston, J. Margolick, R. Burk, 2016, Cancer Causes & Control.

Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study

Ross D. Cranston, C. Hendrix, N. Richardson-Harman, 2014, PloS one.

High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus–Infected Individuals Older Than 26 Years: ACTG 5298

Ross D. Cranston, A. Saah, T. Wilkin, 2017, Sexually transmitted diseases.

Progression of anal high‐grade squamous intraepithelial lesions to invasive anal cancer among HIV‐infected men who have sex with men

Ross D. Cranston, J. Palefsky, E. Holly, 2014, International journal of cancer.

Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study

Ross D. Cranston, T. Holtz, A. Althouse, 2015, Sexually transmitted diseases.

Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study

Ross D. Cranston, J. Margolick, J. Chmiel, 2008, Journal of acquired immune deficiency syndromes.

Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women

Ross D. Cranston, H. Gundacker, A. Carballo-Diéguez, 2018, International journal of STD & AIDS.

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Ross D. Cranston, A. Saah, T. Wilkin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between Free Testosterone Levels and Anal Human Papillomavirus Types 16/18 Infections in a Cohort of Men Who Have Sex with Men

Ross D. Cranston, J. Margolick, R. Detels, 2015, PloS one.

Young gay men and the quadrivalent human papillomavirus vaccine--much to gain (and lose).

Ross D. Cranston, 2014, The Journal of infectious diseases.

Uptake and predictors of anal cancer screening in men who have sex with men.

Ross D. Cranston, D. Ostrow, N. Brewer, 2013, American journal of public health.

Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV

Ross D. Cranston, J. Blanco, R. Cranston, 2022, International journal of STD & AIDS.

The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals

Ross D. Cranston, J. Ordi, J. Mallolas, 2019, International journal of STD & AIDS.

Factors Affecting the Prevalence of Strongly and Weakly Carcinogenic and Lower-Risk Human Papillomaviruses in Anal Specimens in a Cohort of Men Who Have Sex with Men (MSM)

Ross D. Cranston, R. Detels, O. Martínez-Maza, 2013, PloS one.

A Multiple Dose Phase 1 Assessment of Rilpivirine Long-Acting in a Model of Pre-Exposure Prophylaxis against HIV.

Ross D. Cranston, Kaleab Z. Abebe, S. Khoo, 2019, AIDS research and human retroviruses.

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Ross D. Cranston, T. Holtz, A. Carballo-Diéguez, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.

Ross D. Cranston, J. Bauermeister, A. Carballo-Diéguez, 2016, AIDS education and prevention : official publication of the International Society for AIDS Education.

Rectal-Specific Microbicide Applicator: Evaluation and Comparison with a Vaginal Applicator Used Rectally

Ross D. Cranston, J. Bauermeister, A. Carballo-Diéguez, 2014, AIDS and Behavior.

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

James Y. Dai, Ross D. Cranston, A. Carballo-Diéguez, 2013, PloS one.

Acceptability of Potential Rectal Microbicide Delivery Systems for HIV Prevention: A Randomized Crossover Trial

Ross D. Cranston, R. Weiss, P. Anton, 2013, AIDS and Behavior.

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate.

Ross D. Cranston, A. Carballo-Diéguez, W. Cumberland, 2012, AIDS research and human retroviruses.

Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men

Ross D. Cranston, J. Bauermeister, A. Carballo-Diéguez, 2018, AIDS and Behavior.

Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse

Ross D. Cranston, A. Carballo-Diéguez, K. Mayer, 2016, Archives of Sexual Behavior.

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)

Ross D. Cranston, Kaleab Z. Abebe, C. Hendrix, 2015, PloS one.

Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan.

Ross D. Cranston, A. Carballo-Diéguez, K. Mayer, 2015, AIDS education and prevention : official publication of the International Society for AIDS Education.

Immunological responsiveness of intestinal tissue explants and mucosal mononuclear cells to ex vivo stimulation.

Ross D. Cranston, R. Brand, I. McGowan, 2018, Journal of immunological methods.

A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD

Ross D. Cranston, M. Regueiro, N. Richardson-Harman, 2017, Diseases of the colon and rectum.

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.

Ross D. Cranston, Kaleab Z. Abebe, S. Khoo, 2016, The lancet. HIV.

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women

Ross D. Cranston, A. Carballo-Diéguez, S. Park, 2016, PloS one.

Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.

Ross D. Cranston, J. Palefsky, M. Einstein, 2020, AIDS.

A Pilot Study of the Immunologic, Virologic, and Pathologic Consequences of Intra-anal 5% Imiquimod in HIV-1–Infected Men With High-Grade Squamous Intraepithelial Lesions

Ross D. Cranston, I. McGowan, L. Janocko, 2018, Diseases of the colon and rectum.

Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men

Ross D. Cranston, J. Palefsky, S. Buchbinder, 2009, AIDS.

Ross D. Cranston, E. Vittinghoff, J. Palefsky, 2005, Journal of the National Cancer Institute.

Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIV

Ross D. Cranston, J. Palefsky, M. Einstein, 2021, Journal of acquired immune deficiency syndromes.

Anal cytology screening in HIV-positive men who have sex with men: what's new and what's now?

Ross D. Cranston, K. Ho, R. Cranston, 2010, Current opinion in infectious diseases.

The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.

Ross D. Cranston, K. Mayer, C. Hendrix, 2019, AIDS.

The Pharmacokinetics, Pharmacodynamics, and Mucosal Responses to Maraviroc-Containing PrEP Regimens in Men who have Sex with Men

Ross D. Cranston, K. Mayer, C. Hendrix, 2019 .

Oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis increases expression of type I/III interferon-stimulated factors in the gastrointestinal tract but not in the blood

Ross D. Cranston, T. Holtz, J. Baeten, 2019, bioRxiv.

Topical Application of Trichloroacetic Acid Is Efficacious for the Treatment of Internal Anal High-Grade Squamous Intraepithelial Lesions in HIV-Positive Men

Ross D. Cranston, K. Ho, E. Elishaev, 2014, Sexually transmitted diseases.

Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases

Ross D. Cranston, B. Sproat, M. D. Moore, 2010, The Journal of Biological Chemistry.

High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.

Ross D. Cranston, J. Margolick, R. Burk, 2015, The Journal of infectious diseases.